In Brief: Bradley Pharmaceuticals
This article was originally published in The Tan Sheet
Executive Summary
Bradley Pharmaceuticals: Acquires Acid Mantle skin treatment line from Sandoz, Fairfield, N.J.-based Bradley announced May 9. Purchased for less than $1 mil., the line will be marketed by Bradley's Doak Dermatologics subsidiary. Distribution of Acid Mantle with hydrocortisone will begin in the third quarter with accompanying advertising, promotion and sampling efforts. Additional line extensions are planned to follow, the company stated. Other Doak product lines include Carmol body lotions and Formula 405 skin care products...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: